Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the ...

By Arasu Kannagi Basil Feb 24 (Reuters) - Medtronic's MiniMed Group said on Tuesday it was targeting up to $7.86 billion valuation in its U.S. initial public offering, marking a step forward in the ...

(RTTNews) - Medtronic plc. (MDT) announced the U.S. Food and Drug Administration approval for the Simplera Sync sensor for use with the MiniMed 780G system. The MiniMed 780G system now offers more ...

GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...

MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily ...

Medtronic plc MDT recently achieved the CE Mark for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) that does not require any fingersticks or over ...

Medtronic's diabetes spin-off MiniMed seeks $784M IPO at $7.86B valuation after six quarters of double-digit growth in booming CGM market.

GALWAY, Ireland, Feb. 2, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and ...